Literature DB >> 16108766

Flow cytometry of fine-needle-aspiration biopsies: a new method to monitor the intrahepatic immunological environment in chronic viral hepatitis.

D Sprengers1, R G van der Molen, J G Kusters, J Kwekkeboom, L J W van der Laan, H G M Niesters, E J Kuipers, R A De Man, S W Schalm, H L A Janssen.   

Abstract

SUMMARY: Information about the character and grade of the intrahepatic immune response in viral hepatitis is important for the evaluation of disease stage and effect of therapy. Complications like haemorrhage limit the frequent performance of tissue-needle biopsies (TB), and the cells of peripheral blood have to be used as surrogate markers instead. Fine-needle-aspiration biopsy (FNAB) of the liver represents a safe and atraumatic method that allows frequent cytological sampling. Our aim was to investigate whether flow cytometry of FNAB specimens allows co-analysis of phenotype, function and specificity of key populations of liver-infiltrating lymphocytes (LIL). In 20 consecutive patients with chronic viral hepatitis [10 hepatitis B virus (HBV), 10 hepatitis C virus (HCV)], flow cytometry was performed on FNAB cytology, and simultaneously on lymphocytes isolated from a TB and peripheral blood mononuclear cells (PBMC). The ratio of CD8+/CD4+ lymphocytes in FNAB correlated well with LIL from TB (r =0.78, P < 0.05) but differed from PBMC (mean ratio: 2.6, 2.1 and 0.7, respectively). Similarly, a correlation was observed for percentage CD56+ natural killer (NK) cells (mean %: 29.9, 32.3 and 14.5, respectively; r = 0.69, P < 0.05). The percentage of interferon (IFN)-gamma-producing CD3+ lymphocytes in both FNAB and TB was higher than in PBMC (mean %: 41, 44 and 22, respectively; P < 0.05). Furthermore, tetrameric complexes allowed analysis of HBV-specific T cells in FNAB specimens. In conclusion, flow cytometry of FNAB allows easy, atraumatic and reliable analysis of lymphocytes obtained from the intrahepatic compartment. Therefore, the FNAB is a valuable tool in the study of the immunopathology of viral hepatitis, and it may contribute to the improved clinical evaluation of chronic viral liver disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16108766     DOI: 10.1111/j.1365-2893.2005.00626.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  11 in total

1.  Retention of CD4+ CD25+ FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans.

Authors:  Mark A A Claassen; Robert J de Knegt; Harry L A Janssen; André Boonstra
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

Review 2.  Assessing immunological and virological responses in the liver: Implications for the cure of chronic hepatitis B virus infection.

Authors:  Tobias Boettler; Upkar S Gill; Lena Allweiss; Teresa Pollicino; John E Tavis; Fabien Zoulim
Journal:  JHEP Rep       Date:  2022-04-02

Review 3.  Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection.

Authors:  Juan R Larrubia; Selma Benito-Martínez; Miryam Calvino; Eduardo Sanz-de-Villalobos; Trinidad Parra-Cid
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

4.  Gene expression analysis in serial liver fine needle aspirates.

Authors:  S Lejnine; M J Marton; I-M Wang; B J Howell; A L Webber; J W Maxwell; N Shire; V Malkov; J Lunceford; M Zeremski; A Sun; M Ruddy; A H Talal
Journal:  J Viral Hepat       Date:  2014-01-29       Impact factor: 3.728

Review 5.  Adaptive immune response during hepatitis C virus infection.

Authors:  Juan Ramón Larrubia; Elia Moreno-Cubero; Megha Uttam Lokhande; Silvia García-Garzón; Alicia Lázaro; Joaquín Miquel; Cristian Perna; Eduardo Sanz-de-Villalobos
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

6.  Glutathione S-transferase P1 correlated with oxidative stress in hepatocellular carcinoma.

Authors:  Tao Li; Xin-Ping Zhao; Li-Yuan Wang; Shuai Gao; Jing Zhao; Yu-Chen Fan; Kai Wang
Journal:  Int J Med Sci       Date:  2013-04-03       Impact factor: 3.738

7.  Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma.

Authors:  Abdulwahab Ali Gabeen; Fatma Farag Abdel-Hamid; Motawa Eisa El-Houseini; Shadia Abdel-Hamid Fathy
Journal:  J Hepatocell Carcinoma       Date:  2014-06-09

Review 8.  Liver sampling: a vital window into HBV pathogenesis on the path to functional cure.

Authors:  Upkar S Gill; Laura J Pallett; Patrick T F Kennedy; Mala K Maini
Journal:  Gut       Date:  2018-01-13       Impact factor: 23.059

9.  Fine needle aspirates comprehensively sample intrahepatic immunity.

Authors:  Upkar S Gill; Laura J Pallett; Patrick T F Kennedy; Mala K Maini; Niclas Thomas; Alice R Burton; Amit A Patel; Simon Yona
Journal:  Gut       Date:  2018-11-28       Impact factor: 23.059

10.  Gene expression profiling of human tissue-resident immune cells: Comparing blood and liver.

Authors:  Lauke L Boeijen; Gertine W van Oord; Jun Hou; Marieke van der Heide-Mulder; Anuj Gaggar; Li Li; Simon P Fletcher; Robert J de Knegt; André Boonstra
Journal:  J Leukoc Biol       Date:  2018-11-27       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.